References
- Mugnaini EN, Ghosh N. Lymphoma. Prim Care 2016; 43: 661–75. doi: 10.1016/j.pop.2016.07.012
- Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am 2008; 46: 175–98. doi: 10.1016/j.rcl.2008.03.005
- Bairey O, Kremer I, Rakowsky E, Hadar H, Shaklai M. Orbital and adnexal involvement in systemic non-Hodgkin’s lymphoma. Cancer 1994; 73: 2395–99. doi: 10.1002/1097-0142(19940501)73:9<;2395::AIDCNCR2820730924>3.0.CO;2-V
- Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol 2005; 49: 49–55. doi: 10.1007/s10384-004-0147-y
- Sjö LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol 2009; 87: 1–20. doi: 10.1111/j.1755-3768.2008.01478.x
- Coupland SE, White VA, Rootman J, Damato B, Finger PT. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med 2009; 133: 1262–67. doi: 10.5858/133.8.1262
- Bardenstein DS. Ocular adnexal lymphoma: classification, clinical disease, and molecular biology. Ophthalmol Clin North Am 2005; 18: 187–97. doi: 10.1016/j.ohc.2004.11.001
- Coupland SE, Krause L, Delecluse HJ, Anagnostopoulos I, Foss HD, Hummel M, et al. Lymphoproliferative lesions of the ocular adnexa: Analysis of 112 cases. Ophthalmology 1998; 105: 1430–41. doi: 10.1016/S0161-6420(98)98024-1
- McKelvie PA, McNab A, Francis IC, Fox R, O’Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol 2001; 29: 387–93. doi: 10.1046/j.1442-9071.2001.d01-18.x
- Bernardini FP, Bazzan M. Lymphoproliferative disease of the orbit. Curr Opin Ophthalmol 2007; 18: 398–401. doi:10.1097/ICU.0b013e3282be8fbb
- Khan SN, Sepahdari AR. Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies. Saudi J Ophthalmol 2012; 26: 373–83. doi: 10.1016/j.sjopt.2012.08.001
- Sullivan TJ, Valenzuela AA. Imaging features of ocular adnexal lymphoproliferative disease. Eye 2006; 20: 1189–95. doi: 10.1038/sj.eye.6702382
- Hui K-H, Pfeiffer ML, Esmaeli B. Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. Saudi J Ophthalmol 2012; 26: 365–71. doi: 10.1016/j.sjopt.2012.08.008
- J R, VA W, JM C, RD G. Lymphoproliferative, leukemic, and histiocytic lesions of the orbit. In: Rootman J, editor. Diseases of the orbit: a multidisciplinary approach. 2nd Edition. Philadelphia, USA: Lippincott Williams & Wilkins; 2003; p. 385–416.
- Cohen V. Treatment options for ocular adnexal lymphoma (OAL). Clin Ophthalmol 2009; 3: 689–92. doi: 10.2147/OPTH.S5828
- Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LLL. Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 2006; 108: 1451–60. doi:10.1182/blood-2006-02-005017
- Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020; 31: 17–29. doi: 10.1016/j.annonc.2019.10.010
- Graue GF, Finger PT, Maher E, Della Rocca D, Della Rocca R, Lelli GJ Jr, et al. Ocular Adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Eur J Ophthalmol 2013; 23: 344–55. doi: 10.5301/ejo.5000224
- Jezeršek Novaković B. [Recommendations for the management of patients with malignant lymphomas]. [Slovenian]. 2023. Ljubljana: Institute of Oncology Ljubljana. [internet]. [cited 2024 Mar 15]. Available at:
https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/smernice/Priporocila_za_obravnavo_bolnikov_z_malignimi_limfomi_2023.pdf . Published 2023. - Swerdlow S, Campo E, Harris N, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoetic and lmyphoid tissues. 4th edition. Lyon: IARC; 2017.
- Dalvin LA, Salomão DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol 2018; 102: 1728–34. doi: 10.1136/bjophthalmol-2017-311530
- Fernández C, Henry R, Shields C, Bilyk JR, Lally SE, Eagle RC, et al. Ocular adnexal lymphoma: a single-institution retrospective study. Saudi J Ophthalmol 2021; 35: 230–8. doi: 10.4103/1319-4534.343368
- Ferry JA, Fung CY, Zukerberg L, et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 2007; 31: 170–84. doi: 10.1097/01.pas.0000213350.49767.46
- Tanenbaum RE, Galor A, Dubovy SR, Karp CL. Classification, diagnosis, and management of conjunctival lymphoma. Eye Vis 2019; 6: 22. doi: 10.1186/s40662-019-0146-1
- Yen MT, Bilyk JR, Wladis EJ, Bradley EA, Mawn LA. Treatments for ocular adnexal lymphoma. Ophthalmology 2018; 125: 127–36. doi: 10.1016/j.ophtha.2017.05.037
- Rasmussen P, Sjo LD, Prause JU, Ralfkiaer E, Heegaard S. Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol 2009; 93: 1047–51. doi: 10.1136/bjo.2008.146910
- Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol 2019; 64: 45–66. doi: 10.1016/j.survophthal.2018.08.002
- Meunier J, Rouïc LL-L, Dendale R, Vincent-Salomon A, Asselain B, Arnaud P, et al. Conjunctival low-grade non-Hodgkin’s lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leuk Lymphoma 2006; 47: 1295–305. doi: 10.1080/10428190500518966
- White WL, Ferry JA, Harris NL, Grove AS. Ocular adnexal lymphoma. Ophthalmology 1995; 102: 1994–2006. doi: 10.1016/S0161-6420(95)30764-6
- Knowles DM, Jakobiec FA, Mcnally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990; 21: 959–73. doi: 10.1016/0046-8177(90)90181-4
- Andrew NH, Coupland SE, Pirbhai A, Selva D. Lymphoid hyperplasia of the orbit and ocular adnexa: a clinical pathologic review. Surv Ophthalmol 2016; 61: 778–90. doi: 10.1016/j.survophthal.2016.04.004
- Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol 2011; 100: 86–92. doi: 10.1016/j.radonc.2011.05.013
- De Castro B, Peixeiro RP, Mariz JM, Oliveira Â. Ultra-low dose radiotherapy in the management of low-grade orbital lymphomas. Reports Pract Oncol Radiother 2022; 27: 467–73. doi: 10.5603/RPOR.a2022.0044
- Park J, Yea JW, Oh SA, Kim MK, Son JH, Park JW. Prospective study of 4 Gy radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma (FORMAL). Cancers 2022; 14: 4274. doi: 10.3390/cancers14174274
- Tanimoto K, Kaneko A, Suzuki S, Sekiguchi N, Maruyama D, Kim SW, et al. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 2006; 17: 135–40. doi: 10.1093/annonc/mdj025
- Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26: 116–25. doi: 10.1093/annonc/mdv304
- Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 28(Suppl 4): iv62–71. doi: 10.1093/annonc/mdx223
- Portell CA, Aronow ME, Rybicki LA, Macklis R, Singh AD, Sweetenham JW. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone sub-type. Clin Lymphoma Myeloma Leuk 2014; 14: 203–10. doi: 10.1016/j.clml.2013.10.011